Partnership
11 stories covering partnership — fund closes, LP allocations, regulatory filings, deal flow, and fundraising signals from PipelineRoad's editorial team.
AC Immune Amends Morphomer Tau Agreement with Lilly
AC Immune SA announced an amendment to its 2018 license and collaboration agreement with Eli Lilly for Tau aggregation inhibitors, including a CHF10 million upfront payment.
Transgene and NEC Bio Sign License for TG4050 Development in Head and Neck Cancers
Transgene and NEC Bio announced a license agreement on April 2, 2026, for advancing TG4050, a personalized vaccine for HPV-negative head and neck cancers, including financial payments to NEC.
Transgene and NEC Bio Sign License for TG4050 Development
Transgene and NEC Bio have signed a license agreement to advance TG4050 for HPV-negative head and neck cancer treatment, including financial payments.
Advent Technologies and EH Group Enter Fuel Cell Technology Agreement
Advent Technologies has signed a license and joint development deal with EH Group to advance HTPEM fuel cell technology for stationary power applications.
Image Sensing Systems Expands Agreement with Econolite Control Products
Image Sensing Systems, a subsidiary of Autoscope Technologies, announces an eighth modification to its agreement with Econolite, adding a new product to their partnership.
Image Sensing Systems Expands Agreement with Econolite
Image Sensing Systems, a subsidiary of Autoscope Technologies, announces the eighth modification to its agreement with Econolite, adding a new product to their partnership.
Realtor.com and NAR Join for Disaster Housing Relief Efforts
Realtor.com and the National Association of REALTORS announced a partnership to support the REALTORS Relief Foundation's 25th anniversary and disaster aid initiatives.
D - 9038 21ST AVE SW PARTNERS, LLC Files SEC Document
D - 9038 21ST AVE SW PARTNERS, LLC submitted a filing to the SEC on March 12, 2026, as per regulatory records.
EnWave Signs License and Equipment Agreement with Teagasc
EnWave Corporation announced a license agreement and equipment purchase with Teagasc for REV™ technology, as detailed in a GlobeNewswire release.
Hopewell Therapeutics Sublicenses LNPs to Foxcroft for Cancer Vaccine Development
Hopewell Therapeutics grants a global sublicense of its tissue-targeting LNPs to Foxcroft Therapeutics for novel cancer vaccines, including financial terms and planned collaborations.
Menlo Ventures Promotes General Counsel Carrillo to Partner Role
Former math teacher turned legal chief at Menlo Ventures gains partner status, highlighting GCs' expanding influence in venture capital.
